Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF (ARCA: THNR)
Financials · Capital Markets · US
$26.16
-1.02% today · +13.4% 1Y
Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF (ARCA: THNR) operates in the Capital Markets industry within the Financials sector. The company is valued at $5.23M.
Over the last twelve months the share price has gained 13.4%, trading between 21.96 and 27.28.
Tweenvest scores Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF across four factors: dividend 27/100. Its strongest factor is dividend.
THNR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.23M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- 1.58%
- Beta (5Y)
- 0.38
- 52-week high
- $27.28
- 52-week low
- $21.96
- Avg volume (3M)
- —
- Shares outstanding
- 200.00K
- Employees
- —
- Next earnings
- —
About Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF
The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals. Its primary objective is to mirror the investment performance (before any fees or expenses) of the VettaFi Weight Loss Drug & Treatment Index.
- ISIN
- US0321085328
- Founded
- 2024
- Listed since
- May 21, 2024
- Exchange
- NYSE Arca
- Currency
- USD
Other Capital Markets companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETFARCA: VTI | $2.32T | $377.07 | -0.31% |
| Vanguard Index Funds - Vanguard S&P 500 ETFARCA: VOO | $1.66T | $701.83 | -0.27% |
| iShares Trust - iShares Core S&P 500 ETFARCA: IVV | $889.41B | $767.13 | -0.28% |
| State Street SPDR S&P 500 ETF TrustARCA: SPY | $817.93B | $763.47 | -0.29% |
| Invesco QQQ Trust, Series 1NasdaqGM: QQQ | $480.69B | $706.32 | -1.00% |
| Vanguard Index Funds - Vanguard Morningstar Growth ETFARCA: VUG | $377.66B | $86.93 | -0.65% |
| Morgan StanleyNYSE: MS | $336.23B | $214.08 | -0.06% |
| The Goldman Sachs Group, Inc.NYSE: GS | $313.75B | $1,036.28 | -0.29% |
Figures last refreshed Aug 18, 2026.